NanoViricides/$NNVC
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About NanoViricides
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
Ticker
$NNVC
Sector
Primary listing
AMEX
Industry
Biotechnology
Headquarters
Employees
7
ISIN
US6300873022
Website
NanoViricides Metrics
BasicAdvanced
$22M
-
-$0.69
0.91
-
Price and volume
Market cap
$22M
Beta
0.91
52-week high
$1.92
52-week low
$0.94
Average daily volume
267K
Financial strength
Current ratio
2.275
Quick ratio
2.121
Interest coverage (TTM)
-66,224.18%
Profitability
EBITDA (TTM)
-9.094
Management effectiveness
Return on assets (TTM)
-57.38%
Return on equity (TTM)
-99.84%
Valuation
Price to book
2.51
Price to tangible book (TTM)
2.61
Price to free cash flow (TTM)
-2.321
Free cash flow yield (TTM)
-43.09%
Free cash flow per share (TTM)
-59.46%
Growth
Earnings per share change (TTM)
-15.10%
3-year earnings per share growth (CAGR)
-1.90%
10-year earnings per share growth (CAGR)
-16.26%
NanoViricides News
AllArticlesVideos
NanoViricides advances antiviral candidate NV-387 into Phase 2 trials for Mpox
Proactive Investors·2 days ago
NanoViricides touts antiviral NV-387 as tool against new COVID variant
Proactive Investors·2 weeks ago
With Rising Variants of COVID and Bird Flu, the Single Broad-Spectrum Antiviral NV-387 Would be the Best Partner for Preparedness, Says NanoViricides' Dr. Diwan
Accesswire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for NanoViricides stock?
NanoViricides (NNVC) has a market cap of $22M as of July 04, 2025.
What is the P/E ratio for NanoViricides stock?
The price to earnings (P/E) ratio for NanoViricides (NNVC) stock is 0 as of July 04, 2025.
Does NanoViricides stock pay dividends?
No, NanoViricides (NNVC) stock does not pay dividends to its shareholders as of July 04, 2025.
When is the next NanoViricides dividend payment date?
NanoViricides (NNVC) stock does not pay dividends to its shareholders.
What is the beta indicator for NanoViricides?
NanoViricides (NNVC) has a beta rating of 0.91. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.